title: Esophageal acid exposure at pH < or = 2 is more common in Barrett's esophagus patients and is associated with oxidative stress.
abstract: Barrett's esophagus (BE) patients demonstrate a higher distal esophageal acid exposure profile than other gastroesophageal reflux disease patients. Cellular oxidative stress has been proposed to contribute to the development of BE and esophageal adenocarcinoma. However, a relationship between low esophageal pH and oxidative stress has yet to be elucidated. The aim of this study was to determine the duration of low pH exposure in the esophagus of BE patients compared to those with erosive esophagitis (EE) and to test if brief exposure to low pH leads to the induction of reactive oxygen species (ROS). Seventy-three patients with BE or EE were evaluated by 24-hour esophageal pH monitoring and the percentage of time during which there was exposure to pH < or = 4 and pH < or = 2 was recorded. In vitro, Seg-1 and Het-1A cells were evaluated after brief exposure to pH4 or pH2 by flow cytometry and fluorescent microscopy for the production of ROS. BE patients demonstrated a significantly higher exposure to low pH values (pH < or = 2) than EE patients. The mean percent total time, duration and mean number of reflux episodes at pH < or = 2 were 2.8 +/- 0.53%, 28.8 +/- 3.6 seconds and 79 +/- 11.4 episodes in BE patients, whereas in EE patients they were significantly less, 1.16 +/- 0.3%, 15.6 +/- 1.2 seconds and 48.3 +/- 8.8 episodes, respectively (P < 0.05). In vitro experiments indicate that esophageal cells, when exposed to pH 2, produce ROS. In vitro studies using brief pH 2 exposure are biologically relevant to the clinical situation. Our studies indicate that such exposure induces oxidative stress. This stress may cause DNA damage, mutations and progression to cancer.
authors.affiliation: Department of Cell Biology and Anatomy, The University of Arizona, Tucson, AZ 85724, USA.
authors.forename: K
authors.initials: K
authors.lastname: Dvorak
authors.forename: R
authors.initials: R
authors.lastname: Fass
authors.forename: R
authors.initials: R
authors.lastname: Dekel
authors.forename: C M
authors.initials: CM
authors.lastname: Payne
authors.forename: M
authors.initials: M
authors.lastname: Chavarria
authors.forename: B
authors.initials: B
authors.lastname: Dvorakova
authors.forename: H
authors.initials: H
authors.lastname: Bernstein
authors.forename: C
authors.initials: C
authors.lastname: Bernstein
authors.forename: H
authors.initials: H
authors.lastname: Garewal
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism; D001471:Barrett Esophagus / Q000503:physiopathology*; D002460:Cell Line; D004847:Epithelial Cells / Q000378:metabolism; D004938:Esophageal Neoplasms / Q000378:metabolism; D050782:Esophageal pH Monitoring; D004941:Esophagitis / Q000503:physiopathology; D004945:Esophagoscopy; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D017382:Reactive Oxygen Species